Welcome to LookChem.com Sign In|Join Free
  • or
Shenzhen JYMed Technology Co.,Ltd.Enfuvirtide//www.lookchem.com/300w/201001/img/159519-65-0.jpg
qq

Communicate with Supplier:

Ms. Yancey
Ms. Yancey: What can I do for you?

Enfuvirtide CAS NO.159519-65-0

Min.Order Quantity:
1 Gram
Purity:
98%
Port:
Shenzhen
Payment Terms:
L/C,T/T,Other

Add to Inquiry Cart

Product Details

Keywords

  • high purity Enfuvirtide
  • most affordable price
  • CAS# 159519-65-0

Quick Details

  • ProName: Enfuvirtide
  • CasNo: 159519-65-0
  • Molecular Formula: C204H301N51O64
  • Appearance: white powder
  • Application: Human immunodeficiency virus type 1 (H...
  • DeliveryTime: prompt shipment
  • PackAge: according to customer's requirements
  • Port: Shenzhen
  • ProductionCapacity: 2 Kilogram/Month
  • Purity: 98%
  • Storage: 2~8℃
  • Transportation: by air
  • LimitNum: 1 Gram

Superiority

professional peptide manufacturer in china.
high quality with gmp grade
large scale with competitive price
our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.

molecular formula
c204h301n51o64
relative molecular mass
831.97 g/mol
cas-number
159519-65-0 (net)
long-term storage
-20 ± 5°c
sequence

ac-tyr-thr-ser-leu-ile-his-ser-leu-ile-glu-glu-ser-gln-asn-gln-gln-glu-lys-asn-glu-gln-glu-leu-leu-glu-leu-asp-lys-trp-ala-ser-leu-trp-asn-trp-phe-nh2 acetate salt

fields of application

human immunodeficiency virus type 1 (hiv-1) infection

enfuviritide is used in combination with other antiretroviral agents in therapy-experienced patients with evidence of hiv-1 replication despite ongoing antiretroviral therapy.

active substance

enfuvirtide is a 36 amino acid peptide corresponding to a region of gp41, the transmembrane subunit of hiv-1 envelope protein.enfuvitide belongs to the therapeutic class of fusion inhibitors and acts by binding to gp41 and impeding the conformational changes in gp41 necessary for fusion of the virus with the cell.

Details

company profile:
company name:shenzhen jymed technology co.,ltd.
year established:2009
capital: 89.5 million rmb
main product: oxytocin acetate,vasopressin acetate,desmopressin acetate,terlipressin acetate, caspofungin acetate, micafungin sodium, eptifibatide acetate, bivalirudin tfa, deslorelin acetate,glucagon acetate,histrelin acetate,liraglutide acetate,linaclotide aceteate ,degarelix acetate,buserelin acetate,cetrorelix acetate,goserelin
acetate, argireline acetate, metrixyl acetate,snap-8,.....
we strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.jym has successfully submitted a lot
of anda peptide apis and formulated products with cfda and have over fourty patents approved.
our peptide plant is located in nanjing, jiangsu province and it has set up a facility of 30,000 square meters in compliance with cgmp guideline. the manufacture facility has been audited and inspected by both domestic and international clients.
with its excellent quality, most competitive price and strong technical support, jym not only has gained recognitions for its products from research organizations and pharmaceutical industries, but also become one of the most reliable suppliers of peptides in china,. jym is dedicated to be one of the world’s leading peptide provider in the near future.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)